Juno Diagnostics Competitors and Similar CompaniesClear all

Juno Diagnostics's competitors and similar companies include Pattern Genomics, Cambridgene and Corbin Therapeutics.
Juno Diagnostics
Juno Diagnostics
Juno Diagnostics is a company developing a clinical technology platform designed to offer non-invasive DNA-based prenatal testing.
Pattern Genomics
Pattern Genomics
Pattern Genomics is a company that develops Daydreamer, a bioinformatics platform designed to uncover patterns from genomic data sets.
Cambridgene
Cambridgene
Cambridgene (also known as Svastia) is a company that specializes in clinical studies, biomarker discovery, and patient stratification strategies.
Corbin Therapeutics
Corbin Therapeutics
Corbin Therapeutics is a company that develops an in-vivo genome-wide screening platform in mice undergoing experimental neuro-inflammation.
Founding Date
Founding Date
2017
Founding Date
2011
Founding Date
2014
Founding Date
2016
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
San Diego, US HQ
Locations
HQ
Locations
Cambridge, GB HQ
San Francisco, US
Locations
Westmount, CA HQ
Employees
Employees
4
Employees
1
Employees
3
Employees
1

Funding

Latest funding round
Latest funding round
$ 25m (about 5 years ago)
Latest funding round
$ 150k (about 13 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 25m
Total funding raised
$ 150k
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Pattern Genomics
HQ
Employees
1

Pattern Genomics is a company that develops Daydreamer, a bioinformatics platform designed to uncover patterns from genomic data sets.

View company
Cambridgene
HQ
Cambridge, GB
Employees
3

Cambridgene (also known as Svastia) is a company that specializes in clinical studies, biomarker discovery, and patient stratification strategies.

View company
Corbin Therapeutics
HQ
Westmount, CA
Employees
1

Corbin Therapeutics is a company that develops an in-vivo genome-wide screening platform in mice undergoing experimental neuro-inflammation.

View company